Zobrazeno 1 - 6
of 6
pro vyhledávání: '"398"'
Autor:
Deepa Jeyakumar, Ryan D. Cassaday, Roch Houot, Chaoling Feng, Dimitrios Tzachanis, Maria R. Baer, John M. Rossi, Patrick J. Stiff, Marion Subklewe, Max S. Topp, Behzad Kharabi Masouleh, Bijal D. Shah, Remus Vezan, Martha Arellano, Olalekan O. Oluwole, Aaron C Logan, William G. Wierda, Kristen M. O'Dwyer, Tong Shen, Monique C. Minnema, Jinghui Dong, Daniel J. DeAngelo, Nicolas Boissel, Mehrdad Abedi, Francesca Milletti, Gary J. Schiller, Thibaut Leguay, Armin Ghobadi, Michael R. Bishop, Yi Lin, Jae H. Park
Publikováno v:
Lancet
Lancet, Elsevier, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
The Lancet
The Lancet, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
Lancet, Elsevier, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
The Lancet
The Lancet, 2021, 398 (10299), pp.491-502. ⟨10.1016/S0140-6736(21)01222-8⟩
International audience; BACKGROUND: Despite treatment with novel therapies and allogeneic stem-cell transplant (allo-SCT) consolidation, outcomes in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia remain poor, und
Autor:
Obiamiwe Umeh, Rabih O. Darouiche, Judith N. Steenbergen, Florian M.E. Wagenlehner, Guojun Yuan
Publikováno v:
The Lancet. 385:1949-1956
Summary Background Treatment of complicated urinary-tract infections is challenging due to rising antimicrobial resistance. We assessed the efficacy and safety of ceftolozane-tazobactam, a novel antibacterial with Gram-negative activity, in the treat
Autor:
Stéphane Marret, Monique Kaminski, Monique André, Laetitia Marchand, Jean-Charles Picaud, Jean Messer, Jean-Christophe Rozé, Gérard Thiriez, Gérard Bréart, Catherine Arnaud, Antoine Burguet, Béatrice Larroque, Pierre-Yves Ancel, Véronique Pierrat
Publikováno v:
The Lancet
The Lancet, Elsevier, 2008, 371 (9615), pp.813-820. ⟨10.1016/S0140-6736(08)60380-3⟩
The Lancet, 2008, 371 (9615), pp.813-820. ⟨10.1016/S0140-6736(08)60380-3⟩
The Lancet, Elsevier, 2008, 371 (9615), pp.813-820. ⟨10.1016/S0140-6736(08)60380-3⟩
The Lancet, 2008, 371 (9615), pp.813-820. ⟨10.1016/S0140-6736(08)60380-3⟩
Summary Background The increasing survival rates of children who are born very preterm raise issues about the risks of neurological disabilities and cognitive dysfunction. We aimed to investigate neurodevelopmental outcome and use of special health c
Autor:
M. Patrizia Carrieri, Laurent Ferradini, Jacques Izopet, Christopher Brasher, Nathan Ford, Jean-Michel Tassie, Elisabeth Szumilin, Philippe J Guerin, Serge Balandine, Loretxu Pinoges, Gaëlle Fedida, Didakus Odhiambo, Limangeni Mankhambo, Gloria Karungi, Arnaud Jeannin, Bruno Spire
Publikováno v:
The Lancet. 367:1335-1342
BACKGROUND: The recording of outcomes from large-scale, simplified HAART (highly active antiretroviral therapy) programmes in sub-Saharan Africa is critical. We aimed to assess the effectiveness of such a programme held by Médecins Sans Frontières
Publikováno v:
The Lancet. 352:270-274
Summary Background Co-trimoxazole is widely used in treatment of paediatric pneumonia in developing countries, but drug resistance may decrease its effectiveness. We studied the effectiveness of co-trimoxazole compared with that of amoxycillin in pne
Autor:
Robert N. Hoover, L M Licitra, Regina G. Ziegler, Arthur Schatzkin, D B Larson, PhilipR. Taylor, C L Carter
Publikováno v:
The Lancet. 330:298-301
The relation between total serum cholesterol and cancer incidence and mortality was studied in a cohort based on a probability sample of the United States population. 5125 men (yielding 459 incident cancers and 258 cancer deaths) and 7363 women (398